Search

everythinglearnresearchcommunity

for

Search:↓

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

New hair products are being developed to keep hair and scalp healthy for everyone.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

The study found no link between anxiety, vitamin B12, folate, TSH, ferritin, zinc levels, and trichodynia in telogen alopecia patients.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

A specific group of slow-growing stem cells marked by Thy1 is crucial for skin maintenance and healing in mice.

Combining physical dermabrasion with chemical peeling is more effective for skin treatment than chemical peeling alone.

Chronic stress in mice changes skin metabolism and gene expression, leading to hair loss.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Some patients with Alopecia Areata experience itch due to immune cells and enzymes that cause itching.

Gray hair can potentially be reversed, leading to new treatments.

SM-215 promotes hair growth by improving the environment around hair follicles.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Acitretin treatment unexpectedly darkened a patient's gray hair.

Hair aging is caused by stress, hormones, inflammation, and DNA damage affecting hair growth and color.

People with alopecia have a higher risk of thyroid cancer.

Stress-related hair loss was reversed with a special medication.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.